Proteomics

Dataset Information

0

URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers. HEK293T cells were transfected with His-URI plasmid before anti-His immunoprecipitation and gel cutting. LC-MS/MS was performed to identify URI potential binding proteins.


ABSTRACT: URI keeps low levels of p53 in a TRIM28-MDM2 dependent manner, maintains SCD1 activity and accumulation of MUFAs, and subsequently promotes resistance to TKIs in cancer cell. URI-p53-SCD1 axis mediates resistance of TKIs and may explain why p53-wild type HCC still showed intrinsic resistance to TKIs. Moreover, the combination therapy identified here may represent a promising strategy for the approximately 41% of patients with advanced HCC who have wild-type p53 and high levels of URI/SCD1.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture, Early Embryonic Cell

DISEASE(S): Disease Free

SUBMITTER: Zhiwen Ding  

LAB HEAD: Liwei Dong

PROVIDER: PXD045407 | Pride | 2023-09-15

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
LC-MS.zip Other
Test_1.raw Raw
Test_2.raw Raw
Test_3.raw Raw
Test_4.raw Raw
Items per page:
1 - 5 of 7

Similar Datasets

2024-07-20 | PXD044529 | Pride
2019-11-13 | PXD012673 | Pride
2024-09-09 | PXD051958 | Pride
2022-10-12 | PXD035477 | Pride
2024-07-20 | PXD043326 | Pride
2024-07-20 | PXD035424 | Pride
2023-04-19 | PXD039386 | Pride
2024-01-26 | PXD041119 | Pride
2022-03-24 | PXD031890 | Pride
2020-05-26 | PXD012799 | Pride